Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Ciprofloxacin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 10 USDMF, 6 CEP/COS, 7 JDMF, 4 EU WC, 5 KDMF, 3 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

45 Drugs in Development

45 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

678 FDF Dossiers, 60 FDA Orange Book, 343 Europe, 3 Canada, 22 Australia, 88 South Africa, 162 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML), SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 5 SPI Pharma, 7 DKSH, 7 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 35 BASF, 1 BioSpectra, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 39 Disintegrants & Superdisintegrants, 35 Thickeners and Stabilizers, 33 Controlled & Modified Release, 32 Granulation, 32 Direct Compression, 31 Solubilizers, 25 Parenteral, 22 Topical, 21 Lubricants & Glidants, 20 Film Formers & Plasticizers, 17 Taste Masking, 14 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 5 Empty Capsules, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

57 News #PharmaBuzz

57 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 336 Regulatory FDF Prices, 2 Annual Reports

MARKET PLACE

72 APIs, 38 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Neuland Laboratories	India	NEULAND LABORATORIES LTD	18465	CIPROFLOXACIN USP	2005-06-24	Active	II	Complete	2013-04-02	2013-09-27
28/03/2025	Bayer AG	Germany	BAYER AG	8993	CIPROFLOXACIN	1991-02-28	Active	II	N/A

Ciprofloxacin

Ciprofloxacin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers

10 USDMF

6 CEP/COS

7 JDMF

4 EU WC

5 KDMF

3 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

45 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

678 FDF Dossiers

60 FDA Orange Book

343 Europe

3 Canada

22 Australia

88 South Africa

162 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML)

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

5 SPI Pharma

7 DKSH

7 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 ACG Worldwide

12 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

35 BASF

1 BioSpectra

1 Clariant

11 Corel Pharma Chem

6 DFE Pharma

2 Finar

14 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

32 Kerry

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

2 Nanjing Bold Chemical

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

30 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

12 Sigachi Industries

3 The Dow Chemical Company

3 Ulanqab Kema New Material

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders

INJECTABLE;INJECTION - 200MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 400MG/200ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons